Red Flags Detected
- Going Concern (new) — Company discloses uncertainty about ability to continue operations without additional financing or partnership agreements.
Veru partners with Novo Nordisk for obesity trial, grants GLP-1 combo rights
Filed June 4, 2026 · Period ending June 2, 2026 · ~1 min read
4 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade VERU commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 3:51 PM